✦ LIBER ✦

High Incidence of Lung Cancer After Non–Muscle-Invasive Transitional Cell Carcinoma of the Bladder: Implications for Screening Trials

✍ Scribed by Kyle E. Rusthoven; Thomas W. Flaig; David Raben; Brian D. Kavanagh

Book ID: 119935570
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 130 KB
Volume: 9
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2008.n.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

THE MANAGEMENT OF URETHRAL TRANSITIONAL

THE MANAGEMENT OF URETHRAL TRANSITIONAL CELL CARCINOMA AFTER RADICAL CYSTECTOMY FOR INVASIVE BLADDER CANCER

✍ CLARK, P; STEIN, J; GROSHEN, S; MIRANDA, G; CAI, J; LIESKOVSKY, G; SKINNER, D 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 680 KB

Non-muscle invasive transitional cell ca

Non-muscle invasive transitional cell carcinoma of the distal ureter and bladder with lung metastasis: A case report and literature review

✍ Nkwam, Nkwam; Chen, Terng F. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 500 KB

485 MULTI-INSTITUTIONAL QUALITY OF CARE

485 MULTI-INSTITUTIONAL QUALITY OF CARE INITIATIVE FOR NON-METASTATIC MUSCLE-INVASIVE TRANSITIONAL CELL CARCINOMA OF THE BLADDER: PHASE 1

✍ Feifer, Andrew; Taylor, Jennifer; Shouery, Marwan; Savage, Caroline; Steinberg, 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 43 KB

P032 Gene expression profiling for high

P032 Gene expression profiling for high risk progressive non-muscle invasive urothelial cell carcinoma of the bladder

✍ Van Der Heijden, A.G.; Mengual, L.; Ribal, M.J.; Alcaraz, A.; Lozano, J.J.; Fern 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Collateral Activity of Immunotherapy wit

Collateral Activity of Immunotherapy with Bacillus Calmette-Guérin for the Treatment of Non–muscle-invasive Transitional Cell Carcinoma of the Bladder: New Insights

✍ Brausi, Maurizio; Siracusano, Salvatore 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 83 KB

1783 LONG-TERM OUTCOMES OF ELECTRO-MOTIV

1783 LONG-TERM OUTCOMES OF ELECTRO-MOTIVE DRUG ADMINISTRATION OF MITOMYCIN-C AFTER FAILED INTRAVESICAL BCG IMMUNOTHERAPY IN HIGH RISK, NON-MUSCLE INVASIVE TRANSITIONAL CELL CARCINOMA OF THE BLADDER

✍ Crawford, Ruairidh; Wright, Hannah; Borwell, Jonathan; Parker, Theresa; Montgome 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 49 KB